School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage — Seattle, Washington, December 2021–June 2022
Weekly / March 17, 2023 / 72(11);283–287
Tarayn Fairlie, MD1; Brian Chu2; Ebony S. Thomas, MPH1; Audrey K. Querns2; Andie Lyons, MTS3; Melissa Koziol3; Janet A. Englund, MD4; Eric M. Anderson, PhD2; Katherine Graff5; Sara Rigel, MPH3; Teal R. Bell, MPH5; Sharon Saydah, PhD1; Kevin Chatham-Stephens, MD1; Tara M. Vogt, PhD1; Samara Hoag, MN2,*; Melissa Briggs-Hagen, MD1,* (View author affiliations)View suggested citation
What is already known about this topic?
Vaccination decreases risk for COVID-19 illness, severe disease, and death. U.S. pediatric COVID-19 vaccination coverage remains low.
What is added by this report?
Seattle Public Schools implemented a COVID-19 vaccination program through multiple community engagements. During December 2021–June 2022, completion of the primary COVID-19 vaccination series among Seattle Public Schools students aged 5–18 years increased from 56.5% to 80.3%.
What are the implications for public health practice?
School health programs can provide critical information about and access to vaccinations. School health providers might also be able to leverage community partners and relationships with families to increase vaccination coverage.
Views equals page views plus PDF downloads
COVID-19 can lead to severe outcomes in children (1). Vaccination decreases risk for COVID-19 illness, severe disease, and death (2). On December 13, 2020, CDC recommended COVID-19 vaccination for persons aged ≥16 years, with expansion on May 12, 2021, to children and adolescents (children) aged 12–15 years, and on November 2, 2021, to children aged 5–11 years (3). As of March 8, 2023, COVID-19 vaccination coverage among school-aged children remained low nationwide, with 61.7% of children aged 12–17 years and approximately one third (32.7%) of those aged 5–11 years having completed the primary series (3). Intention to receive COVID-19 vaccine and vaccination coverage vary by demographic characteristics, including race and ethnicity and socioeconomic status (4–6). Seattle Public Schools (SPS) implemented a program to increase COVID-19 vaccination coverage during the 2021–22 school year, focusing on children aged 5–11 years during November 2021–June 2022, with an added focus on populations with low vaccine coverage during January 2022–June 2022.† The program included strategic messaging, school-located vaccination clinics, and school-led community engagement. Vaccination data from the Washington State Immunization Information System (WAIIS) were analyzed to examine disparities in COVID-19 vaccination by demographic and school characteristics and trends over time. In December 2021, 56.5% of all SPS students, 33.7% of children aged 5–11 years, and 81.3% of children aged 12–18 years had completed a COVID-19 primary vaccination series. By June 2022, overall series completion had increased to 80.3% and was 74.0% and 86.6% among children aged 5–11 years and 12–18 years, respectively. School-led vaccination programs can leverage community partnerships and relationships with families to improve COVID-19 vaccine access and coverage.
With support from local and state public health officials, SPS conducted school-located vaccination clinics at 54 schools during November 2021–June 2022. WAIIS provides monthly reports on school-required and COVID-19 vaccination coverage to SPS; these data are then linked to school system data. WAIIS data were analyzed to ascertain the monthly proportion of kindergarten through grade 12 students completing the primary COVID-19 vaccination§ series during December 2021–June 2022. The proportions of students completing the primary series were examined by age, race and ethnicity,¶ language status (monolingual versus multilingual),** use of special education services,†† school equity tier,§§ and school baseline vaccination coverage,¶¶ with January 2022 serving as a baseline for assessing subsequent activities to engage groups with low vaccination coverage. Qualitative and descriptive data regarding efforts by SPS to increase primary COVID-19 vaccination series completion during November 2021–June 2022 were also informally collected from approximately 10 SPS staff members and representatives of the Washington Department of Health and Public Health – Seattle & King County (PHSKC) via virtual meetings and e-mail. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.***
SPS serves approximately 50,000 students in 106 schools (Table 1). In December 2021, primary COVID-19 vaccination series completion among SPS students aged 5–18 years was 56.5% overall (Figure) and was lowest among students who were non-Hispanic Black or African American (Black) (27.9%) and multilingual (30.0%). During November–December 2021, 55 school-located vaccination clinics were held, with planning led by SPS and supported by PHSKC. These clinics included school day clinics, where children received immunizations with written parental consent but without requiring that a parent be present, and school-located regional clinics during evening or weekend hours. School-day clinics were strategically located at 41 schools selected because of size or known barriers to care.††† COVID-19 vaccines were also readily available at 29 PHSKC-supported school-based health centers that provide comprehensive primary care to their students.
By January 2022, primary COVID-19 vaccination series completion among SPS students aged 5–18 years had increased from 56.5% to 71.5%. After receipt of school-level student vaccination data in early January 2022, efforts during January–June 2022 focused on schools with continued low (baseline) vaccination coverage. Overall, 26 school-located vaccination clinics were conducted, including 19 during January–March 2022 that were in or near low-coverage schools (i.e., those with primary COVID-19 vaccine series completion rates of ≤50%). These clinics took place after school hours or on the weekend and were open to all SPS students and their family members. SPS administered 12,245 COVID-19 vaccine doses during November 2021–June 2022.
School-located vaccination clinics were complemented by strategies implemented to overcome cultural and linguistic barriers with families. For example, SPS conducted weekly communication with families, including email, telephone calls delivering prerecorded messages, and text messaging using TalkingPoints, a two-way communication platform that provided messaging in six languages.§§§ SPS also provided communications toolkits created by PHSKC in multiple languages to parent-teacher-student associations and community-based organizations to amplify messaging. Vaccine providers were selected based on their cultural competency (e.g., an independent, Black-owned pharmacy with vaccinators with facility in several African languages).
Tailored school-specific engagements were also conducted. One school used multilingual staff members from its school-based health center to administer vaccines at students’ homes or workplaces if necessary, thereby extending vaccination access beyond the school day. This school increased COVID-19 primary series completion among persons aged 11–21 years from 45% in January 2022 to 93% by June 2022. Another worked with a community health organization to organize health-related events focused on the Somali community and cohosted a school-located vaccination clinic with a local mosque. Each school used different approaches; however, all relied on school health staff members for direct family outreach.
During the period in which SPS specifically focused on students and schools with low baseline vaccination coverage, primary COVID-19 vaccination series completion among SPS students increased 12.3%, from 71.5% in January 2022, to 80.3% by June 2022; among children aged 5–11 years and 12–18 years, coverage increased 21.3% and 3.6%, respectively (Table 2). Primary series completion increased 37.8% among Black students (from 33.3% to 45.9%), 121.8% (from 13.5% to 29.9%) among those aged 5–11 years, and 14.8% (from 53.6% to 61.5%) among those aged 12–18 years. During the same period among multilingual students, overall primary series completion increased 38.7% (from 42.6% to 59.1%), 74.6% (from 28.9% to 50.4%) and 10.6% (from 65.7% to 72.3%) among those aged 5–11 and 12–18 years, respectively. Primary series completion among students at schools with low baseline vaccination coverage also increased, from 36.0% to 51.7% (43.4% increase) overall, from 34.8% to 51.1% (46.9% increase) among students aged 5–11 years, and from 51.9% to 58.5% (11.5% increase) among those aged 12–18 years.
These data illustrate the potential impact of active school-based engagement on COVID-19 primary vaccination coverage among students. During the evaluation period, primary series completion in Washington among children aged 5–17 years (42.6%) was similar to national coverage in June 2022 (43.4%) (3,6). Primary series completion among children aged 5–17 years was higher in Seattle and King County (62.2%) than state-wide (42.6%); however, vaccination coverage among children aged 5–18 years in SPS (80.3%) exceeded this completion rate as well (7). Focused engagements during January–June 2022 to improve vaccination coverage might have contributed to high primary series completion among children attending SPS schools. Approaches included improved access via school-located vaccination clinics, outreach by school health professionals, and multimodal, multilingual communication from SPS. Coverage among all subgroups with low coverage in January 2022 significantly increased by June 2022, although overall completion remained lowest among Black and multilingual students.
Schools have the potential to play a critical role in the health of children, and can enhance access to health care services, including preventive care, particularly among those without a traditional medical home. Other studies have described the role of school-located vaccination clinics in increasing human papillomavirus and influenza vaccination coverage among students (8,9). School-located vaccination clinics can increase vaccination coverage by providing equitable access to vaccines but might be more effective when complemented with school-based messaging and other engagements to improve vaccine confidence.
The findings in this report are subject to at least six limitations. First, the intervention did not include a comparison group; thus, it is not possible to assess the relative contribution of these school-based activities to the changes in primary series completion described. Second, place of vaccination was not reported, and students might have been vaccinated at non-SPS vaccination sites. Third, monthly primary series completion data are cross-sectional, reflecting primary series completion for each subgroup at a single point in time; thus, the change in primary series completion for each subgroup cannot be attributed to individual change in behavior. Fourth, primary series completion data might be inaccurate or missing if students were vaccinated out of state. Fifth, caregivers of children in SPS might be more vaccine-confident compared with those in other U.S. populations, as suggested by high COVID-19 vaccination coverage in Seattle and King County (6). Finally, other interventions that affected vaccine confidence or access to care might not have been considered.
These findings illustrate and highlight the critical role that school health can play within the community. School health professionals are likely to be trusted by families (10). In this report, school health professionals collaborated with community and public health partners to implement strategic engagements and to facilitate opportunities for COVID-19 vaccination. School-led promotion of vaccination might improve vaccine confidence and provide support and readiness for current and future pandemics.
Corresponding author: Tarayn Fairlie, email@example.com.
1CDC COVID-19 Emergency Response Team; 2Seattle Public Schools, Seattle, Washington; 3Public Health – Seattle & King County, Seattle, Washington; 4Seattle Children’s Hospital, Seattle, Washington; 5Washington State Department of Health.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Janet A. Englund reports institutional support from Pfizer, GlaxoSmithKline, AstraZeneca, and Merck; consulting fees from Pfizer, Moderna, Abbvie, Merck, and AstraZeneca; and travel support to attend the 2022 European Society for Paediatric Infectious Diseases meeting from AstraZeneca. No other potential conflicts of interest were disclosed.
* These senior authors contributed equally to this report.
† CDC recommended COVID-19 vaccination for persons aged ≥16 years on December 13, 2020, for children aged 12–15 years on May 12, 2021, and for children aged 5–11 years on November 2, 2021. Booster doses for children aged 12–17 years were recommended in October 2021, and booster doses for children aged 5–11 years were recommended on May 19, 2022. During the period described, SPS focused efforts on children aged 5–11 years to maximize primary series vaccination coverage in that age group, although booster doses were available, advertised, and encouraged as well.
§ Defined as having completed the primary series of a COVID-19 vaccine approved or authorized by the Food and Drug Administration or listed for emergency use by the World Health Organization.
¶ Defined by student self-report or caregiver report at time of school registration.
** Language status as monolingual or multilingual learner; multilingual learners were defined as those using English language learning (ELL) services during the 2021–22 school year. Students using ELL services spoke a variety of other languages at home or as a first language, including Amharic, Arabic, Cantonese, Japanese, Mandarin, Oromo, Russian, Somali, Soninke, Spanish, Tigrinya, Toishanese, and Vietnamese.
†† Having an individual education plan during the 2021–22 school year.
§§ School equity tier defined using established SPS methodology. Tier 1 and Tier 2 schools represent higher levels of inequity and are designated for additional support from the state; Tier 3 and Tier 4 schools have lower levels of inequity and do not qualify for additional support. https://www.seattleschools.org/wp-content/uploads/2022/02/tier_methodology23.pdf
¶¶ The proportion of a school’s students who had completed the primary series by the first week of January 2022. SPS school health staff members defined schools with low vaccination coverage as those with a student primary COVID-19 vaccination series completion rate of ≤50%; high-coverage schools were those with a completion rate of >50%.
*** 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.
††† Prioritized schools included those with >500 students, Equity Tier 1–3 schools, schools with programs for medically fragile students and with deaf and hard of hearing students, and schools whose students had less access to other large-scale vaccination opportunities.
§§§ TalkingPoints is a two-way multilingual communication platform for schools and families. SPS uses this platform to engage with families in multiple languages (Amharic, English, Mandarin, Somali, Spanish, and Vietnamese) about school-related issues, including school-located vaccination clinics for COVID-19 vaccine. https://talkingpts.org/schools
- Marks KJ, Whitaker M, Anglin O, et al.; COVID-NET Surveillance Team. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:271–8. https://doi.org/10.15585/mmwr.mm7107e4 PMID:35176003
- Higdon MM, Wahl B, Jones CB, et al. A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease. Open Forum Inf Dis 2022;9:ofac138. https://doi.org/10.1093/ofid/ofac138 PMID:35611346
- CDC. COVID-19 vaccine ACIP vaccine recommendations. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed January 3, 2023. https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html
- CDC. COVID data tracker: trends in demographic characteristics of people receiving COVID-19 vaccinations in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed March 8, 2023. https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends
- CDC. COVID data tracker: trends in COVID-19 vaccine confidence in the US. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed August 25, 2022. https://covid.cdc.gov/covid-data-tracker/#vaccine-confidence
- Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Willingness, refusal and influential factors of parents to vaccinate their children against the COVID-19: a systematic review and meta-analysis. Prev Med 2022;157:106994. https://doi.org/10.1016/j.ypmed.2022.106994 PMID:35183597
- Washington State Department of Health. COVID-19 vaccination progress dashboard and data. Olympia, WA: Washington State Department of Health; 2022. Accessed July 22, 2022. https://doh.wa.gov/emergencies/covid-19/vaccine-information/dashboards-and-data
- Underwood NL, Gargano LM, Sales J, Vogt TM, Seib K, Hughes JM. Evaluation of educational interventions to enhance adolescent specific vaccination coverage. J Sch Health 2019;89:603–11. https://doi.org/10.1111/josh.12786 PMID:31161606
- Szilagyi PG, Schaffer S, Rand CM, et al. School-located influenza vaccination: do vaccine clinics at school raise vaccination rates? J Sch Health 2019;89:1004–12. https://doi.org/10.1111/josh.12840 PMID:31612491
- Albright K, Barnard J, O’Leary S, et al. School-based health centers as medical homes: parents’ and adolescents’ perspectives. Acad Pediatr 2016;16:381–6. https://doi.org/10.1016/j.acap.2015.06.004 PMID:26329018
FIGURE. Completion of the primary COVID-19 vaccination series by students aged 5–18 years, by race and ethnicity* (A) and school coverage status,† student language status, and equity tier§ (B) — Seattle Public Schools, December 2021–June 2022
Abbreviations: ET = equity tier; SLVC = school-located vaccination clinic.
* Hispanic or Latino students could be of any race; other racial groups were non-Hispanic. American Indian or Alaska Native students (215), Native Hawaiian or other Pacific Islander students (197), and students with missing race and ethnicity data (18) are excluded from figure.
† Low- and high-coverage schools have primary COVID-19 series completion rates of ≤50% and >50%, respectively.
§ Tier 1 and Tier 2 schools represent higher levels of inequity and are designated for additional support from the state; Tier 3 and Tier 4 schools have lower levels of inequity and do not qualify for additional support. https://www.seattleschools.org/wp-content/uploads/2022/02/tier_methodology23.pdf
Suggested citation for this article: Fairlie T, Chu B, Thomas ES, et al. School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage — Seattle, Washington, December 2021–June 2022. MMWR Morb Mortal Wkly Rep 2023;72:283–287. DOI: http://dx.doi.org/10.15585/mmwr.mm7211a3.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.